Literature DB >> 7823024

Neurotransmitter transporters: three important gene families for neuronal function.

G R Uhl1, P S Johnson.   

Abstract

Three distinct gene families encode transporter proteins that aid in temporal and spatial buffering of neurotransmitter and neurotransmitter metabolite concentrations and allow neurons to cycle and recycle transmitter molecules. Analyses of these gene families and their products are likely to enhance understanding of the molecular neurobiology of neuronal function and may elucidate contributors to the genetic etiologies of neurological and psychiatric disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7823024     DOI: 10.1242/jeb.196.1.229

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  25 in total

1.  Permeation and gating residues in serotonin transporter.

Authors:  J G Chen; G Rudnick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Am J Ther       Date:  2009 Jul-Aug       Impact factor: 2.688

Review 3.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

Review 4.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

5.  Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter.

Authors:  M E Reith; C Xu; L Zhang; L L Coffey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.

Authors:  Sarojini M Sengupta; Natalie Grizenko; Geeta A Thakur; Johanne Bellingham; Rosherrie DeGuzman; Sandra Robinson; Marina TerStepanian; Anna Poloskia; S M Shaheen; Marie-Eve Fortier; Zia Choudhry; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

Review 7.  Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  AAPS J       Date:  2007-01-05       Impact factor: 4.009

8.  High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors:  Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal:  Eur J Neurosci       Date:  2007-09-06       Impact factor: 3.386

Review 9.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

10.  Glycosyl modification facilitates homo- and hetero-oligomerization of the serotonin transporter. A specific role for sialic acid residues.

Authors:  Deniz Ozaslan; Sophie Wang; Billow A Ahmed; Arif M Kocabas; John C McCastlain; Anca Bene; Fusun Kilic
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.